Preview this article 1 min The dispute centers on prescription drug claims between 2020 and 2022. Charter alleges the ...
The Federal Trade Commission has reached a landmark settlement with Express Scripts, banning practices that favored high-priced drugs and requiring expanded access to lower-cost options. The deal is ...
The Federal Trade Commission has reached a landmark settlement with Express Scripts, addressing allegations of inflated drug prices and rebate-driven formulary exclusions. The agreement bans the PBM ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results